| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 24 | 2025 | 887 | 3.130 |
Why?
|
| Mutation, Missense | 11 | 2025 | 946 | 1.690 |
Why?
|
| Genetic Variation | 10 | 2025 | 1597 | 1.310 |
Why?
|
| Genetic Fitness | 6 | 2024 | 37 | 1.050 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2024 | 788 | 0.820 |
Why?
|
| Amino Acid Substitution | 6 | 2025 | 415 | 0.820 |
Why?
|
| Phenotype | 16 | 2025 | 4577 | 0.680 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2025 | 2855 | 0.650 |
Why?
|
| Evolution, Molecular | 5 | 2019 | 707 | 0.620 |
Why?
|
| Mutation | 20 | 2025 | 6343 | 0.590 |
Why?
|
| Genome, Human | 3 | 2024 | 1340 | 0.570 |
Why?
|
| Databases, Genetic | 8 | 2025 | 505 | 0.570 |
Why?
|
| Genetic Testing | 3 | 2025 | 1101 | 0.520 |
Why?
|
| Germ-Line Mutation | 2 | 2017 | 368 | 0.520 |
Why?
|
| Sequence Analysis, DNA | 2 | 2019 | 1830 | 0.510 |
Why?
|
| Intellectual Disability | 4 | 2025 | 1096 | 0.460 |
Why?
|
| Open Reading Frames | 1 | 2014 | 220 | 0.430 |
Why?
|
| Genotype | 4 | 2022 | 2720 | 0.420 |
Why?
|
| Genetics, Medical | 1 | 2014 | 123 | 0.420 |
Why?
|
| Exome | 3 | 2024 | 1086 | 0.410 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2025 | 548 | 0.410 |
Why?
|
| Calmodulin | 2 | 2024 | 223 | 0.370 |
Why?
|
| Humans | 61 | 2025 | 133373 | 0.350 |
Why?
|
| Models, Genetic | 7 | 2022 | 786 | 0.350 |
Why?
|
| ROC Curve | 3 | 2025 | 606 | 0.340 |
Why?
|
| Autism Spectrum Disorder | 3 | 2021 | 430 | 0.340 |
Why?
|
| Mitochondrial Proteins | 2 | 2025 | 256 | 0.340 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2025 | 3363 | 0.330 |
Why?
|
| Mitochondrial Diseases | 2 | 2025 | 151 | 0.330 |
Why?
|
| Proteins | 4 | 2014 | 1090 | 0.330 |
Why?
|
| Head and Neck Neoplasms | 5 | 2023 | 635 | 0.330 |
Why?
|
| Escherichia coli | 3 | 2023 | 1031 | 0.330 |
Why?
|
| Neoplasms | 3 | 2022 | 2992 | 0.280 |
Why?
|
| Chemistry, Physical | 2 | 2007 | 31 | 0.280 |
Why?
|
| Gene Frequency | 3 | 2025 | 753 | 0.280 |
Why?
|
| Algorithms | 7 | 2024 | 1730 | 0.270 |
Why?
|
| Cell Cycle Proteins | 3 | 2019 | 702 | 0.260 |
Why?
|
| Biophysics | 1 | 2006 | 52 | 0.260 |
Why?
|
| Cisplatin | 3 | 2023 | 286 | 0.250 |
Why?
|
| A Kinase Anchor Proteins | 2 | 2018 | 21 | 0.240 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2025 | 9 | 0.240 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2016 | 789 | 0.230 |
Why?
|
| Breast Neoplasms | 4 | 2024 | 2762 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2025 | 97 | 0.230 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2025 | 115 | 0.220 |
Why?
|
| Ribonucleotides | 1 | 2024 | 32 | 0.220 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2024 | 69 | 0.220 |
Why?
|
| RNA Stability | 1 | 2024 | 87 | 0.220 |
Why?
|
| Hyperparathyroidism | 1 | 2024 | 26 | 0.210 |
Why?
|
| Reproducibility of Results | 3 | 2022 | 3043 | 0.210 |
Why?
|
| Genetic Association Studies | 3 | 2017 | 860 | 0.210 |
Why?
|
| Models, Molecular | 7 | 2021 | 1147 | 0.210 |
Why?
|
| Ovarian Neoplasms | 2 | 2019 | 468 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 218 | 0.200 |
Why?
|
| Selection, Genetic | 3 | 2022 | 168 | 0.200 |
Why?
|
| Software | 2 | 2025 | 732 | 0.200 |
Why?
|
| Protein Stability | 5 | 2024 | 175 | 0.190 |
Why?
|
| Calculi | 1 | 2022 | 15 | 0.190 |
Why?
|
| RNA Splicing | 1 | 2024 | 254 | 0.190 |
Why?
|
| Rare Diseases | 1 | 2024 | 209 | 0.180 |
Why?
|
| Phylogeny | 3 | 2021 | 781 | 0.180 |
Why?
|
| Mobile Applications | 1 | 2023 | 109 | 0.180 |
Why?
|
| Nucleic Acids | 1 | 2021 | 27 | 0.180 |
Why?
|
| Severe Acute Respiratory Syndrome | 1 | 2021 | 37 | 0.180 |
Why?
|
| Xanthines | 1 | 2021 | 13 | 0.180 |
Why?
|
| Glycoside Hydrolases | 1 | 2021 | 17 | 0.180 |
Why?
|
| Apraxias | 1 | 2021 | 15 | 0.180 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2025 | 335 | 0.170 |
Why?
|
| Thermodynamics | 3 | 2025 | 146 | 0.170 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2020 | 21 | 0.170 |
Why?
|
| Lung Neoplasms | 2 | 2025 | 1558 | 0.170 |
Why?
|
| Acetylglucosaminidase | 1 | 2019 | 12 | 0.160 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2019 | 14 | 0.160 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2021 | 128 | 0.160 |
Why?
|
| Yeasts | 1 | 2019 | 43 | 0.160 |
Why?
|
| Escherichia coli Proteins | 1 | 2022 | 316 | 0.160 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2019 | 35 | 0.160 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 138 | 0.160 |
Why?
|
| Antineoplastic Agents | 2 | 2023 | 1849 | 0.160 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 50 | 0.160 |
Why?
|
| Iron-Binding Proteins | 1 | 2019 | 32 | 0.160 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2017 | 118 | 0.160 |
Why?
|
| Circular Dichroism | 3 | 2025 | 86 | 0.160 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2022 | 384 | 0.150 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 82 | 0.150 |
Why?
|
| Sex Factors | 1 | 2023 | 1353 | 0.150 |
Why?
|
| Protein Conformation | 6 | 2019 | 873 | 0.150 |
Why?
|
| Computer Simulation | 5 | 2019 | 708 | 0.150 |
Why?
|
| Blood Glucose | 1 | 2023 | 1185 | 0.150 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 3794 | 0.150 |
Why?
|
| Autoantigens | 1 | 2019 | 115 | 0.150 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2018 | 3 | 0.150 |
Why?
|
| Methyltransferases | 1 | 2019 | 83 | 0.150 |
Why?
|
| Viral Vaccines | 1 | 2021 | 345 | 0.150 |
Why?
|
| Amino Acyl-tRNA Synthetases | 1 | 2018 | 26 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 1 | 2018 | 19 | 0.140 |
Why?
|
| Hepatectomy | 1 | 2019 | 124 | 0.140 |
Why?
|
| GTP Phosphohydrolases | 1 | 2019 | 156 | 0.140 |
Why?
|
| Phosphorylation | 5 | 2025 | 1707 | 0.140 |
Why?
|
| Biological Evolution | 2 | 2022 | 254 | 0.140 |
Why?
|
| Anoctamins | 1 | 2017 | 14 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 177 | 0.140 |
Why?
|
| Sequence Alignment | 1 | 2019 | 631 | 0.140 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 2 | 2018 | 11 | 0.140 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 606 | 0.140 |
Why?
|
| Mitochondria | 2 | 2025 | 755 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 258 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 5 | 0.140 |
Why?
|
| Autistic Disorder | 1 | 2021 | 379 | 0.140 |
Why?
|
| Pyruvate Kinase | 1 | 2017 | 11 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2023 | 829 | 0.140 |
Why?
|
| Codon | 1 | 2017 | 102 | 0.130 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2018 | 172 | 0.130 |
Why?
|
| Job Syndrome | 1 | 2016 | 17 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2017 | 330 | 0.130 |
Why?
|
| Precision Medicine | 2 | 2019 | 361 | 0.130 |
Why?
|
| Schizophrenia | 1 | 2019 | 330 | 0.130 |
Why?
|
| Benchmarking | 1 | 2017 | 146 | 0.120 |
Why?
|
| False Positive Reactions | 1 | 2016 | 140 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 498 | 0.120 |
Why?
|
| Female | 19 | 2025 | 71503 | 0.120 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2017 | 172 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 882 | 0.120 |
Why?
|
| Antiviral Agents | 1 | 2021 | 824 | 0.120 |
Why?
|
| Tongue Neoplasms | 1 | 2015 | 30 | 0.110 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 62 | 0.110 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2018 | 277 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 230 | 0.110 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 2145 | 0.110 |
Why?
|
| Serine Endopeptidases | 2 | 2014 | 199 | 0.110 |
Why?
|
| Imidazoles | 1 | 2015 | 218 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 94 | 0.110 |
Why?
|
| Piperazines | 1 | 2015 | 256 | 0.110 |
Why?
|
| Morbidity | 1 | 2014 | 255 | 0.110 |
Why?
|
| Genetics, Population | 1 | 2014 | 192 | 0.100 |
Why?
|
| Neoplasm Metastasis | 1 | 2016 | 745 | 0.100 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2014 | 234 | 0.100 |
Why?
|
| Models, Chemical | 3 | 2011 | 90 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1420 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 639 | 0.100 |
Why?
|
| Nuclear Proteins | 2 | 2020 | 1341 | 0.100 |
Why?
|
| Monte Carlo Method | 3 | 2007 | 102 | 0.090 |
Why?
|
| Rec A Recombinases | 1 | 2011 | 26 | 0.090 |
Why?
|
| Desmosterol | 1 | 2011 | 3 | 0.090 |
Why?
|
| Crystallography, X-Ray | 2 | 2024 | 393 | 0.090 |
Why?
|
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 1 | 2011 | 5 | 0.090 |
Why?
|
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2011 | 7 | 0.090 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2011 | 23 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1612 | 0.090 |
Why?
|
| Polymorphism, Genetic | 1 | 2014 | 814 | 0.090 |
Why?
|
| Hyperammonemia | 1 | 2011 | 62 | 0.090 |
Why?
|
| DNA Mutational Analysis | 2 | 2011 | 841 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2575 | 0.080 |
Why?
|
| Mice, Nude | 3 | 2018 | 780 | 0.080 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 1036 | 0.080 |
Why?
|
| Binding Sites | 3 | 2019 | 1378 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 612 | 0.080 |
Why?
|
| Bacterial Proteins | 2 | 2014 | 924 | 0.080 |
Why?
|
| Male | 11 | 2025 | 65592 | 0.080 |
Why?
|
| Ribonucleotide Reductases | 1 | 2009 | 11 | 0.080 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2009 | 29 | 0.080 |
Why?
|
| Gastrointestinal Motility | 1 | 2009 | 56 | 0.080 |
Why?
|
| Child, Preschool | 5 | 2025 | 14873 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2014 | 551 | 0.070 |
Why?
|
| Apoptosis | 1 | 2015 | 1928 | 0.070 |
Why?
|
| Signal Transduction | 2 | 2018 | 4917 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1411 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2021 | 607 | 0.070 |
Why?
|
| Myocardium | 1 | 2013 | 924 | 0.070 |
Why?
|
| Animals | 9 | 2024 | 36222 | 0.070 |
Why?
|
| DNA, Mitochondrial | 1 | 2009 | 243 | 0.070 |
Why?
|
| Machine Learning | 2 | 2025 | 344 | 0.070 |
Why?
|
| Protein Binding | 3 | 2018 | 1852 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 1838 | 0.070 |
Why?
|
| Ions | 1 | 2006 | 22 | 0.060 |
Why?
|
| Hydrogen Bonding | 1 | 2006 | 87 | 0.060 |
Why?
|
| Molecular Conformation | 1 | 2006 | 111 | 0.060 |
Why?
|
| Solvents | 1 | 2006 | 46 | 0.060 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2024 | 440 | 0.060 |
Why?
|
| Temperature | 1 | 2006 | 326 | 0.060 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 353 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 2092 | 0.060 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 2651 | 0.060 |
Why?
|
| Adult | 6 | 2025 | 31684 | 0.060 |
Why?
|
| RNA-Binding Motifs | 1 | 2024 | 3 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2018 | 806 | 0.050 |
Why?
|
| Cell Survival | 2 | 2018 | 884 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2018 | 432 | 0.050 |
Why?
|
| Adolescent | 4 | 2025 | 20573 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2006 | 500 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 1013 | 0.050 |
Why?
|
| Mutation Rate | 1 | 2023 | 72 | 0.050 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2023 | 37 | 0.050 |
Why?
|
| HEK293 Cells | 2 | 2018 | 824 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 5044 | 0.050 |
Why?
|
| Young Adult | 3 | 2025 | 9923 | 0.050 |
Why?
|
| Survival Rate | 2 | 2019 | 2207 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2024 | 2125 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2023 | 235 | 0.050 |
Why?
|
| Colistin | 1 | 2022 | 33 | 0.050 |
Why?
|
| Adiposity | 1 | 2023 | 207 | 0.050 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2023 | 131 | 0.050 |
Why?
|
| Ciprofloxacin | 1 | 2022 | 69 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2013 | 150 | 0.050 |
Why?
|
| Child | 4 | 2025 | 25868 | 0.050 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIbeta Subunit | 1 | 2021 | 2 | 0.050 |
Why?
|
| Pedigree | 1 | 2025 | 1730 | 0.040 |
Why?
|
| Mice | 4 | 2024 | 18936 | 0.040 |
Why?
|
| Zebrafish | 1 | 2024 | 422 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2021 | 127 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2024 | 2720 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2021 | 180 | 0.040 |
Why?
|
| Cystathionine | 1 | 2019 | 5 | 0.040 |
Why?
|
| Protein Domains | 1 | 2021 | 260 | 0.040 |
Why?
|
| Proteome | 1 | 2021 | 282 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2021 | 180 | 0.040 |
Why?
|
| Middle Aged | 4 | 2024 | 28985 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2019 | 74 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 835 | 0.040 |
Why?
|
| Homocysteine | 1 | 2019 | 120 | 0.040 |
Why?
|
| Fungal Proteins | 1 | 2019 | 143 | 0.040 |
Why?
|
| Protein Folding | 1 | 2019 | 222 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2017 | 2559 | 0.040 |
Why?
|
| Glucose | 1 | 2023 | 917 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 21500 | 0.040 |
Why?
|
| Insulin | 1 | 2023 | 1245 | 0.040 |
Why?
|
| DNA Repair | 1 | 2021 | 573 | 0.040 |
Why?
|
| Paraplegia | 1 | 2018 | 89 | 0.040 |
Why?
|
| Phenylalanine | 1 | 2018 | 134 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 470 | 0.040 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 314 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2019 | 325 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2019 | 809 | 0.030 |
Why?
|
| Fructosediphosphates | 1 | 2017 | 3 | 0.030 |
Why?
|
| Allosteric Site | 1 | 2017 | 12 | 0.030 |
Why?
|
| Linear Models | 1 | 2019 | 719 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2018 | 249 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2018 | 148 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2017 | 64 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 2016 | 31 | 0.030 |
Why?
|
| Solutions | 2 | 2007 | 67 | 0.030 |
Why?
|
| Heat Shock Transcription Factors | 1 | 2016 | 21 | 0.030 |
Why?
|
| Crystallization | 2 | 2007 | 88 | 0.030 |
Why?
|
| Diterpenes | 1 | 2016 | 29 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 89 | 0.030 |
Why?
|
| Half-Life | 1 | 2016 | 162 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2021 | 2785 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 163 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2016 | 120 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2016 | 130 | 0.030 |
Why?
|
| Spleen | 1 | 2016 | 287 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2019 | 415 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2014 | 36 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2014 | 91 | 0.030 |
Why?
|
| DNA | 1 | 2020 | 1676 | 0.030 |
Why?
|
| Pyrimidinones | 1 | 2014 | 59 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 238 | 0.030 |
Why?
|
| Calcium | 1 | 2019 | 1099 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 260 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 1118 | 0.030 |
Why?
|
| Mitosis | 1 | 2014 | 205 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2015 | 1097 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 964 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2014 | 313 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 453 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2016 | 674 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 509 | 0.030 |
Why?
|
| Cricetulus | 1 | 2013 | 97 | 0.030 |
Why?
|
| CHO Cells | 1 | 2013 | 167 | 0.030 |
Why?
|
| Feedback | 1 | 2014 | 172 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 721 | 0.030 |
Why?
|
| Cellular Senescence | 1 | 2014 | 200 | 0.030 |
Why?
|
| Cricetinae | 1 | 2013 | 395 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 676 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 7141 | 0.020 |
Why?
|
| Base Sequence | 1 | 2017 | 3153 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2019 | 3418 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2014 | 334 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1137 | 0.020 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2011 | 8 | 0.020 |
Why?
|
| Age Determination by Skeleton | 1 | 2011 | 11 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 527 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2440 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2014 | 420 | 0.020 |
Why?
|
| DNA Damage | 1 | 2014 | 517 | 0.020 |
Why?
|
| Homologous Recombination | 1 | 2011 | 100 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 329 | 0.020 |
Why?
|
| INDEL Mutation | 1 | 2011 | 94 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 1473 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2011 | 144 | 0.020 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2011 | 117 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1378 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 1608 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 896 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3718 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 13243 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 2009 | 64 | 0.020 |
Why?
|
| RNA, Transfer | 1 | 2009 | 77 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2009 | 204 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2011 | 3869 | 0.020 |
Why?
|
| Exons | 1 | 2011 | 825 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2024 | 13103 | 0.020 |
Why?
|
| Brain | 2 | 2011 | 3223 | 0.020 |
Why?
|
| Pregnancy | 1 | 2021 | 7602 | 0.020 |
Why?
|
| Transcriptome | 1 | 2015 | 1135 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 1433 | 0.020 |
Why?
|
| Chemical Phenomena | 1 | 2007 | 87 | 0.020 |
Why?
|
| Scattering, Radiation | 1 | 2007 | 57 | 0.020 |
Why?
|
| Bacillus subtilis | 1 | 2007 | 50 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 89 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 616 | 0.020 |
Why?
|
| Phase Transition | 1 | 2006 | 18 | 0.020 |
Why?
|
| Genomics | 1 | 2015 | 1676 | 0.020 |
Why?
|
| Static Electricity | 1 | 2006 | 47 | 0.020 |
Why?
|
| Light | 1 | 2007 | 183 | 0.020 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2006 | 65 | 0.020 |
Why?
|
| Biopsy | 1 | 2009 | 1204 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1583 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1152 | 0.010 |
Why?
|
| United States | 1 | 2019 | 11722 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2009 | 1041 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8632 | 0.010 |
Why?
|